In the last trading session, 1.07 million shares of the GeneDx Holdings Corp (NASDAQ:WGS) were traded, and its beta was 2.00. Most recently the company’s share price was $99.00, and it changed around $4.65 or 4.93% from the last close, which brings the market valuation of the company to $2.78B. WGS currently trades at a discount to its 52-week high of $115.60, offering almost -16.77% off that amount. The share price’s 52-week low was $7.72, which indicates that the current value has risen by an impressive 92.2% since then.
GeneDx Holdings Corp stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended WGS as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. GeneDx Holdings Corp is expected to report earnings per share of 0.11 for the current quarter.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Instantly WGS has showed a green trend with a performance of 4.93% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 106.73 on recent trading dayincreased the stock’s daily price by 7.24%. The company’s shares are currently up 28.81% year-to-date, but still up 3.29% over the last five days. On the other hand, GeneDx Holdings Corp (NASDAQ:WGS) is 32.26% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $70, which translates to bulls needing to decrease their stock price by -41.43% from its current value. Analyst projections state that WGS is forecast to be at a low of $70 and a high of $70.
GeneDx Holdings Corp (WGS) estimates and forecasts
The year-over-year growth rate is expected to be 17.40%, up from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 79.9M in revenue for the current quarter. 6 analysts expect GeneDx Holdings Corp to make 85.32M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 62.42M and 70.51M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 27.99%. Forecasts for the next quarter put sales growth at 20.99%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 96.65%. GeneDx Holdings Corp earnings are expected to increase by 248.68% in 2025, but the outlook is positive 119.03% per year for the next five years.
WGS Dividends
GeneDx Holdings Corp’s next quarterly earnings report is expected to be released in April.
CORVEX MANAGEMENT LP, with 9.2937% or 2.47 million shares worth $64.66 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Alger Small Cap Focus Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Oct 31, 2024 . The former held 461.76 shares worth $45.71 million, making up 1.65% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 410.78 shares worth around $40.67 million, which represents about 1.46% of the total shares outstanding.
